Pharming Group (OTCMKTS:PHGUF) Stock Passes Below 50-Day Moving Average – What’s Next?

Pharming Group (OTCMKTS:PHGUF)’s share price crossed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $0.90 and traded as low as $0.87. Pharming Group shares last traded at $0.87, with a volume of 1,000 shares changing hands.

Pharming Group Price Performance

The stock’s 50 day simple moving average is $0.90 and its 200-day simple moving average is $0.83. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.76 and a current ratio of 3.53. The firm has a market cap of $582.83 million, a price-to-earnings ratio of -43.43 and a beta of 1.00.

Pharming Group Company Profile

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome.